Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

CytomX Therapeutics (CTMX) Tax Provisions (2016 - 2025)

Historic Tax Provisions for CytomX Therapeutics (CTMX) over the last 9 years, with Q3 2025 value amounting to $58000.0.

  • CytomX Therapeutics' Tax Provisions fell 491.8% to $58000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $245000.0, marking a year-over-year decrease of 8008.13%. This contributed to the annual value of $224000.0 for FY2024, which is 9424.46% down from last year.
  • CytomX Therapeutics' Tax Provisions amounted to $58000.0 in Q3 2025, which was down 491.8% from $63000.0 recorded in Q2 2025.
  • Over the past 5 years, CytomX Therapeutics' Tax Provisions peaked at $2.8 million during Q3 2023, and registered a low of $49000.0 during Q1 2024.
  • Moreover, its 3-year median value for Tax Provisions was $62000.0 (2024), whereas its average is $477555.6.
  • As far as peak fluctuations go, CytomX Therapeutics' Tax Provisions tumbled by 9783.92% in 2024, and later surged by 2653.06% in 2025.
  • CytomX Therapeutics' Tax Provisions (Quarter) stood at $1.1 million in 2023, then crashed by 94.2% to $62000.0 in 2024, then fell by 6.45% to $58000.0 in 2025.
  • Its last three reported values are $58000.0 in Q3 2025, $63000.0 for Q2 2025, and $62000.0 during Q1 2025.